Your browser doesn't support javascript.
loading
Autonomic balance determines the severity of COVID-19 courses.
Leitzke, M; Stefanovic, D; Meyer, J-J; Schimpf, S; Schönknecht, P.
Afiliación
  • Leitzke M; Department of Anesthesiology, Helios Clinics, Colditzer Straße 48, 04703, Leisnig, Germany. marco.leitzke@gmx.de.
  • Stefanovic D; Department of Anesthesiology, Helios Clinics, Colditzer Straße 48, 04703, Leisnig, Germany.
  • Meyer JJ; Department of Anesthesiology, Helios Clinics, Colditzer Straße 48, 04703, Leisnig, Germany.
  • Schimpf S; Drägerwerk AG & Co. KGaA, Moislinger Allee 53-55, 23558, Lübeck, Germany.
  • Schönknecht P; Medical faculty of Leipzig University, Saxon Hospital, Hufelandstraße 15, Sächsisches Krankenhaus, 01477, Arnsdorf, Germany.
Bioelectron Med ; 6(1): 22, 2020 Nov 24.
Article en En | MEDLINE | ID: mdl-33292846
ABSTRACT
COVID-19 has left mankind desperately seeking how to manage dramatically rising infection rates associated with severe disease progressions. COVID-19 courses range from mild symptoms up to multiple organ failure and death, triggered by excessively high serum cytokine levels (IL 1ß, IL 6, TNF α, IL 8). The vagally driven cholinergic anti-inflammatory pathway (CAP) stops the action of nuclear factor κB (NF-κB), the transcriptional factor of pro-inflammatory cytokines. Thus, well-balanced cytokine release depends on adequate vagal signaling. Coronaviruses replicate using NF-κB transcriptional factor as well. By degrading the cytoplasmatic inhibitor of NF-κB subunits (IκB), coronaviruses induce unrestricted NF-κB expression accelerating both, virus replication and cytokine transcription.We hypothesize that CAP detriment due to depressed vagal tone critically determines the severity of COVID-19.
Palabras clave